LAGUNA HILLS, Calif., March 31 /PRNewswire-FirstCall/ -- CalbaTech, Inc. (OTC Bulletin Board: CLBE), the emerging life sciences company (http://www.CalbaTech.com ) concentrating on the collection and banking of adult stem cells for possible future therapeutic uses, today announced the Company decreased debt by $999,926 in 2007.
CalbaTech announced revenues of $1.149 million in 2007, down slightly from $1.250 million in 2006. Gross profit in 2007 totaled $662,849. Net income in 2007 was $27,940 compared to $13,801 in 2006.
"The significant decrease in debt is a major achievement for our financial stability and our future prospects," said James DeOlden, CEO. "We are also pleased to announce that the very first harvesting of adult stem cells by LifeStem(TM) will occur at the Youthtopia Med Spa, near Atlanta, on May 10th."
Mr. DeOlden also announced that "Keller Medical Institute, the well respected medical group headquartered in Monterey, California, which is marketing and selling the LifeStem(TM) service for the collection of healthy adult stem cells for future medical use, has added three physicians to its LifeStem training program."
LifeStem(TM) is a wholly owned subsidiary of CalbaTech. The procedure it developed for the harvesting of adult stem cells uniquely involves the collection of both blood and adipose tissue. The process allows for the collection of adult stem cells in micro quantities to be cryopreserved for future transplantation into the same client, with possible future medical therapies ranging from heart disease to diabetes and other diseases that are currently difficult to treat.
About CalbaTech
CalbaTech, Inc. (OTC Bulletin Board: CLBE) is the emerging life
sciences company (http://www.CalbaTech.com), concentrating on providing
products and platforms to the research market for biotech and
pharmace
'/>"/>
| SOURCE CalbaTech, Inc. Copyright©2008 PR Newswire. All rights reserved |